A Phase 2, Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel-Group Study with an Open-Label Extension to Evaluate the Efficacy, Safety, and Pharmacokinetics of E5501 in Subjects with Chronic Hepatitis C Virus-Related Thrombocytopenia wh
|Effective start/end date||12/22/11 → 8/3/12|
- EISAI MEDICAL RESEARCH INC.
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.